Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ceftazidime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental ceftazidime overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional ceftazidime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de ceftazidime d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Ceftizoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental ceftizoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional ceftizoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Ceftizoxime overdose of undetermined intent |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefixime overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental cefixime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional cefixime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de céfixime d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefodizime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental cefodizime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional cefodizime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefodizime overdose of undetermined intent |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefpodoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental cefpodoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional cefpodoxime overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefpodoxime overdose of undetermined intent |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Ceftriaxone overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental ceftriaxone overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional ceftriaxone overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de ceftriaxone d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Ceftibuten overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental ceftibuten overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional ceftibuten overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de ceftibutène d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefsulodin overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental cefsulodin overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional cefsulodin overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefsulodin overdose of undetermined intent |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Fourth generation cephalosporin overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Cefpirome overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental cefpirome overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional cefpirome overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de cefpirome d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Tetracycline group overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Doxycycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental doxycycline overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional doxycycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de doxycycline d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Minocycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental minocycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional minocycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de minocycline d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Oxytetracycline overdose (disorder) |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental oxytetracycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional oxytetracycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose d'oxytétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Tetracycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental tetracycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional tetracycline overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de tétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Chloramphenicol overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Accidental chloramphenicol overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Intentional chloramphenicol overdose |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de chloramphénicol d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose accidentelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose intentionnelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
surdose de sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
Bactericide |
Inferred relationship |
Some |
|
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Sulfasalazine 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Sulfasalazine 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Sulfasalazine 3g/100mL retention enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Tobramycin 300mg/5mL nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Medicinal product containing penicillinase-sensitive penicillin and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Benzylpenicillin sodium 600 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing benethamine penicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing benzathine benzylpenicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Medicinal product containing broad spectrum penicillin and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin + clavulanate potassium 400mg/57mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Amoxicillin + clavulanate potassium 250mg/62.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Some |
|